Tirzepatide 20mg

Tirzepatide 20mg – A Dual GIP and GLP-1 Receptor Agonist

Tirzepatide is a synthetic peptide that acts as an agonist at both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual mechanism makes it a powerful compound in research on metabolic diseases.

Composition and Function

Tirzepatide is a 39-amino acid peptide engineered to mimic the actions of endogenous GIP and GLP-1. By activating both receptors, it enhances glucose-dependent insulin secretion, suppresses glucagon release, slows gastric emptying, and promotes satiety. These effects contribute to improved glycemic control and significant weight loss.

Research Applications

Tirzepatide is used in research to study its effects on type 2 diabetes, obesity, and cardiovascular health. It is a key compound for investigating the synergistic effects of dual receptor agonism on metabolic pathways.

Storage and Handling

Store Tirzepatide in a lyophilized state at -20°C, protected from light. After reconstitution, keep it at 4°C and use within a short timeframe. Avoid repeated freeze-thaw cycles.

• Dual GIP and GLP-1 receptor agonist
• Enhances insulin secretion and promotes satiety
• Suppresses glucagon and delays gastric emptying
• Used in diabetes, obesity, and cardiovascular research
• Supplied as a 20mg lyophilized powder

Disclaimer: This product is for research purposes only. It is not intended for human consumption, medical treatment, or diagnostic use.